4//SEC Filing
Zanganeh Mahkam 4
Accession 0001599298-25-000060
CIK 0001599298other
Filed
Apr 8, 8:00 PM ET
Accepted
Apr 9, 5:19 PM ET
Size
10.7 KB
Accession
0001599298-25-000060
Insider Transaction Report
Form 4
Zanganeh Mahkam
DirectorCo-Chief Executive Officer10% Owner
Transactions
- Exercise of In-Money
Warrant (right to buy)
2025-04-08+3,985,055→ 0 total(indirect: By Spouse)Exercise: $1.58From: 2020-06-24Exp: 2029-12-24→ Common Stock (3,985,055 underlying) - Exercise of In-Money
Common Stock
2025-04-08$1.58/sh+3,985,055$6,296,387→ 555,680,151 total(indirect: By Spouse)
Holdings
- 10,199,776(indirect: By Trust)
Common Stock
- 25,457,666(indirect: By Trust)
Common Stock
- 50,000(indirect: Immediate family member)
Common Stock
- 31,000
Common Stock
Footnotes (2)
- [F1]On April 8, 2025, the Reporting Person's spouse exercised warrants to purchase an aggregate of 3,985,055 shares of the Issuer's common stock at an exercise price of $1.58 per share
- [F2]The Reporting Person disclaims beneficial ownership of these securities, except to the extent of her pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001507650
Filing Metadata
- Form type
- 4
- Filed
- Apr 8, 8:00 PM ET
- Accepted
- Apr 9, 5:19 PM ET
- Size
- 10.7 KB